1. Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of Immunotherapy Response
   John Nemunaitis et al, 2023, Cancers CrossRef
2. Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
   Fang-Ying Chiu et al, 2023, Biomarker Research CrossRef
3. Dendritic Cells (DCs)-Based Cancer Immunotherapy: A Review on the Prospects of Medicinal Plants and Their Phytochemicals as Potential Pharmacological Modulators
   Md. Selim Ahmed et al, 2022, Applied Sciences CrossRef
4. Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond
   Salvatore Perrone et al, 2023, Cancers CrossRef
5. Immunologic tumor microenvironment modulators for turning cold tumors hot
   Gholam‐Reza Khosravi et al, 2024, Cancer Communications CrossRef
6. The role of immune subtyping in glioma mRNA vaccine development
   Alexandro Guterres et al, 2023, Immunotherapy CrossRef
7. Identification of effect of gene mutations related to telomere maintenance in gastric cancer patients
   Anju R. Nath et al, 2024, Medicine in Omics CrossRef
8. Plasmid DNA for Therapeutic Applications in Cancer
   David Hernán Martínez-Puente et al, 2022, Pharmaceutics CrossRef
9. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
   Jiangping Li et al, 2023, Molecular Cancer CrossRef
10. Tumor necrosis factor alpha and lipopolysaccharides synergistic effects on T-cell immunoglobulin and mucin domain 3 regulation in dendritic cells
    Alia Aldahlawi et al, 2022, Journal of King Saud University - Science CrossRef
11. Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors
    Faizah Alotaibi et al, 2024, Frontiers in Pharmacology CrossRef